Skip to Main Content

Paper Details

<i>PIK3CA</i> mutant tumors depend on oxoglutarate dehydrogenase.
Proc Natl Acad Sci U S A
33
2017
2-oxoglutarate, 2-oxoglutarate dehydrogenase, 2OG, NAD+, NADH, OGDH, Oncogenic PIK3CA mutations, PI3K, PIK3CA, PIK3CA mutant, PIK3CA mutant cancer cells, PIK3CA mutant cell, PIK3CA mutant cells, PIK3CA mutant tumors, aspartate, cancer, cancer cell, cancers, glucose, human, malate, mutant PIK3CA, mutant cells, oncogenic, oncogenic PIK3CA, oxoglutarate, oxoglutarate dehydrogenase, recurrently mutated oncogene, tumors
Author NameAffiliation
Barbara A WeirDana-Farber Cancer Institute, Harvard Medical School
Barbara A WeirBroad Institute of MIT and Harvard University
Barbara A WeirDana-Farber Cancer Institute, Harvard Medical School
Barbara A WeirBroad Institute of MIT and Harvard University
Aviad TsherniakBroad Institute of MIT and Harvard University
Aviad TsherniakBroad Institute of MIT and Harvard University
Glenn S CowleyBroad Institute of MIT and Harvard University
David E RootBroad Institute of MIT and Harvard University
David E RootBroad Institute of MIT and Harvard University
Francisca VazquezDana-Farber Cancer Institute, Harvard Medical School
Francisca VazquezBroad Institute of MIT and Harvard University
David M SabatiniBroad Institute of MIT and Harvard University
David M SabatiniWhitehead Institute for Biomedical Research
David M SabatiniDavid H. Koch Institute for Integrative Cancer Research at MIT
David M SabatiniHoward Hughes Medical Institute, Massachusetts Institute of Technology
David M SabatiniMassachusetts Institute of Technology
William C HahnDana-Farber Cancer Institute, Harvard Medical School
William C HahnBroad Institute of MIT and Harvard University
William C HahnDana-Farber Cancer Institute, Harvard Medical School
William C HahnBroad Institute of MIT and Harvard University
  • 1 - 20

Datasets

Release 1.2